These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28833217)

  • 1. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
    J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
    Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
    Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
    Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
    Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
    Ajmani GS; Nocon CC; Wang CH; Bhayani MK
    Oral Oncol; 2017 Nov; 74():15-20. PubMed ID: 29103745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
    Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
    Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
    Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
    Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
    Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.
    Scharpf J; Ward M; Adelstein D; Koyfman S; Li M
    Laryngoscope; 2018 Apr; 128(4):823-830. PubMed ID: 28891087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
    Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
    Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
    Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
    Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
    Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.